RTP biotech inks potential $400M+ deal with Bayer subsidiary


A biotech in Research Triangle Park has landed millions in cash through a new collaboration, with a chance to earn hundreds of millions more.

Previous Moderna snags two wins with Covid-19 booster authorization, Merck deal
Next Mary Ellen's Bistro closes in Northeast Minneapolis